Elke Holinski-Feder
Overview
Explore the profile of Elke Holinski-Feder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
4371
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benet-Pages A, Laner A, Nassar L, Wohlfrom T, Steinke-Lange V, Haeussler M, et al.
Genet Med Open
. 2025 Mar;
3:101961.
PMID: 40027238
Purpose: Variants of uncertain significance (VUS) are considered one of the most significant impediments to the translation of genetic test results into precise clinical recommendations. The 2015 American College of...
2.
Henkel J, Laner A, Locher M, Wohlfrom T, Neitzel B, Becker K, et al.
Breast
. 2025 Jan;
80:103887.
PMID: 39854808
As multigene panel testing is becoming routine in clinical care, there are recommendations at national and international level, as to which genes should be analyzed in the context of a...
3.
Wendlandt M, Erdmann H, Rost S, Lucas M, Becker K, Kleinle S, et al.
Neurol Genet
. 2024 Dec;
11(1):e200220.
PMID: 39703464
Background And Objectives: Myotonic dystrophy type 2 (DM2) is a multisystemic repeat disorder caused by the expansion of an unstable CCTG tetranucleotide repeat in the noncoding region of the gene....
4.
Steinke-Lange V, Holinski-Feder E
Pathologie (Heidelb)
. 2024 Jun;
45(4):290-299.
PMID: 38864870
Patients with Lynch syndrome, one of the most common hereditary tumor predisposition syndromes, harbor an increased risk for a broad spectrum of especially gastrointestinal and gynecological tumors. Causative for the...
5.
Hallermayr A, Kessler T, Steinke-Lange V, Heitzer E, Holinski-Feder E, Speicher M
Med Genet
. 2024 Jun;
35(4):275-284.
PMID: 38835734
Liquid biopsy for minimally invasive diagnosis and monitoring of cancer patients is progressing toward routine clinical practice. With the implementation of highly sensitive next-generation sequencing (NGS) based assays for the...
6.
Barseghyan H, Eisenreich D, Lindt E, Wendlandt M, Scharf F, Benet-Pages A, et al.
Genes (Basel)
. 2024 Mar;
15(3).
PMID: 38540401
Chromosome analysis (CA) and chromosomal microarray analysis (CMA) have been successfully used to diagnose genetic disorders. However, many conditions remain undiagnosed due to limitations in resolution (CA) and detection of...
7.
Hallermayr A, Kessler T, Fujera M, Liesfeld B, Bernstein S, von Ameln S, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894392
Background: Liquid biopsy enables the non-invasive analysis of genetic tumor variants in circulating free DNA (cfDNA) in plasma. Accurate analytical validation of liquid biopsy NGS assays is required to detect...
8.
Moller P, Seppala T, Ahadova A, Crosbie E, Holinski-Feder E, Scott R, et al.
Hered Cancer Clin Pract
. 2023 Oct;
21(1):19.
PMID: 37821984
The recognition of dominantly inherited micro-satellite instable (MSI) cancers caused by pathogenic variants in one of the four mismatch repair (MMR) genes MSH2, MLH1, MSH6 and PMS2 has modified our...
9.
Kleinle S, Scholz V, Benet-Pages A, Wohlfrom T, Gehling S, Scharf F, et al.
J Neuromuscul Dis
. 2023 Jul;
10(5):835-846.
PMID: 37424474
Background: The importance of early diagnosis of 5q-Spinal muscular atrophy (5q-SMA) has heightened as early intervention can significantly improve clinical outcomes. In 96% of cases, 5q-SMA is caused by a...
10.
Quintana I, Terradas M, Mur P, Te Paske I, Peters S, Spier I, et al.
Genes Dis
. 2023 Jul;
10(3):753-757.
PMID: 37396538
No abstract available.